Grünenthal PRO is joining SHL Medical’s alliance partnership network to offer final assembly service for Molly® autoinjectors
4.9.2025 10:00:00 CEST | news aktuell GmbH | Press Release
Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery systems. Through this collaboration, Grünenthal PRO will offer final assembly, packaging and labelling of Molly® autoinjector.
Grünenthal PRO will expand its capacity for final assembly of SHL autoinjectors by installing additional assembly lines in its Origgio, Italy facility in 2026. These new pre-validated lines for Molly® 1.0 and 2.25 mL autoinjector platform will enhance speed-to-market for pharma and biotech companies, building on Grünenthal’s 10 year-experience in SHL autoinjector assembly services.
In parallel, SHL customers will benefit from access to Grünenthal PRO’s established expertise and capacity in delivering high quality, reliable contract manufacturing services.
“Speed-to-market is a decisive advantage in today’s biopharma landscape,” says Victor Barbosa, Executive Vice President of Global Operations at Grünenthal. “With our deep expertise in autoinjector final assembly and the new high-speed line launching in 2026, Grünenthal is uniquely positioned to deliver agile, large-scale solutions. Our collaboration with SHL enhances this capability, reinforcing our role as a trusted CDMO partner for injectable therapies worldwide.”
Molly® is a single-dose autoinjector built on modular platform technology that helps pharma and biotech companies reduce initial investments and accelerate timelines. Molly® boasts an unparalleled track record in combination product approvals and is designed to meet the evolving requirements of future autoinjectors.
Markus Puusepp, SHL Medical’s Chief Growth Officer, commented on the collaboration: “This new partnership builds on several years of successful project collaboration between SHL Medical and Grünenthal PRO for joint customers. We’re excited to deepen our collaboration by officially welcoming Grünenthal PRO as a strategic partner, further strengthening our trusted relationship.”
The new Molly® autoinjector assembly line to be installed by Grünenthal PRO will be procured from SHL Advantec, a sub-group of SHL Medical and global provider of high-performance, fully integrated precision tooling and advanced automation solutions for the healthcare sector and other industries.
About SHL Medical
As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose – Enabling Patients’ Independence – SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems.
Located across Switzerland, Taiwan, Sweden, and the US, SHL Medical’s global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth.
For additional information, visit http://www.shl-medical.com/
About Grünenthal PRO
Grünenthal PRO is the contract manufacturing division of Grünenthal, offering end-to-end services in pharmaceutical assembly, packaging, and labelling. With a strong focus on injectable therapies and advanced automation, Grünenthal PRO supports global pharma and biotech companies in accelerating time-to-market and ensuring high-quality delivery. For more information, visit www.grunenthal-pro.com.
For additional information, visit www.grunenthal-pro.com
SHL
Media contact
Christine Mueller
Corporate Communications
info@shl-medical.com
+41 41 368 00 00
Grünenthal PRO
Media contact
Grünenthal PRO Communications
info@grunenthal-pro.com
+49 (0)241 569-0
https://www.grunenthal-pro.com/contact-us
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Amid Mounting Global Health Crises, World Health Summit Closes in Berlin with New Commitments14.10.2026 14:13:51 CEST | Press Release
Berlin, October 14, 2026 - The World Health Summit 2026 concluded with new funding commitments, research findings, and initiatives. Under the theme “From Crisis to Resilience: Innovating for Health,” the Summit convened more than 4,000 on-site participants from 130 countries and territories, generated over 50,000 livestream views, and featured more than 400 speakers, including 20 ministers and state secretaries, across 76 sessions.
Innomotics Receives Prestigious EcoVadis Silver Medal – First Assessment Places Company Among Top 15% Globally12.10.2026 11:00:00 CEST | Press Release
Nuremberg – Innomotics, a globally leading provider of electric motors and large drive systems, has earned the coveted EcoVadis Silver Medal in its first-ever assessment. With a strong score of 74 out of 100 points, the company now ranks among the global top 15% of more than 150,000 rated companies. First EcoVadis Rating as Innomotics Participation in the EcoVadis assessment marks an important milestone in Innomotics’ sustainability journey. As a relatively young, independent organization, the first rating provided the opportunity to benchmark its sustainability management against an internationally recognized framework and demonstrate the progress made since becoming a standalone company. Silver Medal: Top 15% Globally The EcoVadis Silver Medal is awarded to the top 15% of companies assessed worldwide. With its achieved score of 74 points, Innomotics not only confirms its position within this leading group but also demonstrates that it meets the rating’s rising requirements – the thre
World Health Summit 2026: Berlin Becomes Global Meeting Point for the Future of Health12.10.2026 08:13:31 CEST | Press Release
Berlin, October 11, 2026 The World Health Summit (WHS) 2026, the leading platform for global health, brings together more than 4,000 participants from 130 countries in Berlin and tens of thousands more online from October 11 to 13. Under the theme "From Crisis to Resilience: Innovating for Health," the Summit convenes leaders from politics, science, civil society, and the private sector. Discussions address Ebola and other infectious diseases, antibiotic resistance, pandemic preparedness, resilient health systems, health care in conflict settings such as Ukraine, and climate-related health threats. The Summit will also address WHO leadership through a conversation with prospective candidates for the next WHO Director-General. Against this backdrop, WHS President Axel R. Pries emphasized the need for innovation and collaboration: "Past achievements and continued progress in global health are increasingly challenged by multiple and overlapping crises. To build resilient, effective, and e
DRF Aviation Services launches on October 1, 20261.10.2026 11:28:06 CEST | Press Release
DRF Luftrettung and DRF Maintenance are joining forces: the newly established DRF Aviation Services combines the two companies’ technical expertise built on more than 50 years of experience in helicopter maintenance, modifications and services. As a “one-stop shop”, DRF Aviation Services provides the full range of services from a single source. Helicopter operators benefit from high levels of reliability and innovative capability.
RM Equity Partners (RMEP) completes generational handover – partners take full ownership1.10.2026 09:30:11 CEST | Press Release
Ruggell (LI), 1 October 2026 – RM Equity Partners (RMEP), the international investment firm focused on asset-light digital businesses, today announces the completion of its generational handover. As of 1 October 2026, the management company is fully owned by the three partners Eugen Benedikt Russ, Chris Wittlinger and Nicola Szekely and the wider team, who will make all new investments independently. With this step, the succession within the founding family is concluded: RMEP operates as a fully independent investment firm with no ownership, management or personnel ties to the Russmedia group. RMEP has grown into one of the most active investors in digital marketplaces, software and consumer platforms in Europe: Assets under management of more than €500 million Annual investment capacity of more than €100 million 50+ portfolio investments, with 95% of revenue generated outside Austria Independent evergreen structure – the partners invest their own capital (principal investing, no exter
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom